The current SGRY market cap is 3.07B. The company's latest EPS is USD -0.0940 and P/E is -264.26.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 616.1M | 753.6M | 667.3M | 667.6M | 674.1M |
Operating Income | 74.6M | 150.4M | 60.2M | 89.1M | 90.8M |
Net Income | -25M | -23.4M | -24.9M | 18.9M | -4.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.83B | 1.91B | 2.28B | 2.59B | 2.75B |
Operating Income | 219.9M | 188.7M | 304.4M | 371.2M | 357.9M |
Net Income | -110.5M | -155.6M | -81.2M | -54.6M | -11.9M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.54B | 6.68B | 6.64B | 6.62B | 6.78B |
Total Liabilities | 4.09B | 3.4B | 3.36B | 3.31B | 3.46B |
Total Equity | 2.11B | 2.94B | 2.94B | 2.98B | 2.99B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 5.02B | 5.41B | 6.12B | 6.68B | 6.88B |
Total Liabilities | 3.32B | 3.79B | 3.82B | 3.4B | 3.51B |
Total Equity | 983.4M | 882.1M | 1.97B | 2.94B | 3.03B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 151.6M | 158.8M | 74.5M | 126.6M | 231.2M |
Investing | -235.7M | -307.9M | -70.7M | -141.9M | -167.5M |
Financing | -151M | 42.1M | -41.2M | -90.2M | -110.6M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 129.5M | 246.9M | 87.1M | 158.8M | 293.8M |
Investing | -85.2M | -88.4M | -331.7M | -307.9M | -225.6M |
Financing | -135.9M | 66.7M | 316.3M | 42.1M | -155.2M |
Market Cap | 3.07B |
Price to Earnings Ratio | -264.26 |
Price to Sales Ratio | 1.14 |
Price to Cash Ratio | 16.05 |
Price to Book Ratio | 0.94 |
Dividend Yield | - |
Shares Outstanding | 126.61M |
Average Volume (1 week) | 1.03M |
Average Volume (1 Month) | 809.78k |
52 Week Change | -38.23% |
52 Week High | 45.79 |
52 Week Low | 22.05 |
Spread (Intraday) | 0.04 (0.16%) |
Company Name | Surgery Partners Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.surgerypartners.com |
Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.